Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy
Ali Ghasemi, Amaia Martinez‐Usatorre, L. Li, et al.
Nature Cancer (2023) Vol. 5, Iss. 2, pp. 240-261
Open Access | Times Cited: 21

Showing 21 citing articles:

Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors
Lucía López, Luciano Gastón Morosi, Federica La Terza, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Designing drug delivery systems for cell therapy
Liwen Wang, Yongsheng Gao, Zhaoqianqi Feng, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 944-959
Closed Access | Times Cited: 6
Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications
Wei Mao, Hyuk Sang Yoo
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 5
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Yanyan Zheng, Jiawei Wang, Guangya Zhao, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010521-e010521
Open Access
In-situ trichosanthin-IL2/pectin dynamic hydrogel activates dendritic cells and reverses T cell exhaustion for post-operative cancer therapy
Zeyun Gu, Guihua Chen, Nan Gao, et al.
Chemical Engineering Journal (2025) Vol. 505, pp. 159426-159426
Closed Access
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Inflammasome activation in melanoma progression: the latest update concerning pathological role and therapeutic value
Nakaraj Pluetrattanabha, Thanyaporn Direksunthorn, Irfan Ahmad, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity
Hazal Aslan Rejeski, Anne Hartz, Elias Rackl, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Recent developments in myeloid immune modulation in cancer therapy
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis
Jianhao Bai, Zhongqi Wan, Wanru Zhou, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
Cancer vaccines: from an immunology perspective
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity
Thu Nguyen, R Müller, Daria Briukhovetska, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2608-2608
Open Access | Times Cited: 2
Emerging cytokine delivery with nanomedicine for brain cancer treatment
Flávia Sousa
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 513-516
Open Access | Times Cited: 1
Unlocking Immunity: Innovative prostate cancer vaccine strategies
Qiannan Gu, Anning Qi, Ne Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113137-113137
Closed Access | Times Cited: 1
Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide
Junyong Wang, Yuan Tang, Xuelian Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
DCs targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors
Lucía López‐Rodríguez, Luciano Gastón Morosi, Federica La Terza, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy
Zhiyu Zhang, Lu Yu, Wenjing Liu, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 184-199
Closed Access
Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors
Nima Taghizadeh Mortezaei, Adrina Habibzadeh, Zahra Rahimian, et al.
Interdisciplinary cancer research (2024)
Closed Access
Biomaterials and Nanomedicines: Progress in Cancer Research
Aya Hamid Mohammad Qalawlus, Muhammad Sohail
Interdisciplinary cancer research (2024)
Closed Access
Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method
Zhijun Dai, Chao Chen, Ziyan Zhou, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 2133-2144
Open Access
Cytokine-overexpressing dendritic cells for cancer immunotherapy
Joonsu Han, Hua Wang
Experimental & Molecular Medicine (2024)
Open Access
Page 1

Scroll to top